Understanding how HIV-1 proteins interact to improve treatment strategies
HIV-1 Gag Precursor Protein Interactions
['FUNDING_R01'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-10839823
This study is looking at how certain proteins in the HIV virus work together to help the virus multiply, with the goal of finding new ways to stop HIV from spreading, which could lead to better treatments for people living with the virus.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-10839823 on ClinicalTrials.gov |
What this research studies
This research investigates the interactions of HIV-1 structural proteins, particularly focusing on the N-terminal matrix domain of the precursor Gag proteins. By examining how these proteins are synthesized and their role in targeting virus assembly sites, the research aims to uncover new methods to inhibit HIV replication. The approach includes studying the binding of Gag proteins to specific lipids and their influence on the incorporation of envelope proteins into virus particles. This could lead to the development of novel therapeutic strategies for HIV treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who may benefit from new treatment strategies.
Not a fit: Patients who are not infected with HIV or those who have already exhausted all available treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively inhibit HIV replication and improve outcomes for patients living with HIV/AIDS.
How similar studies have performed: Previous research has shown promise in understanding HIV protein interactions, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BARKLIS, ERIC W — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: BARKLIS, ERIC W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.